Skip to main content

Table 2 Sequence alignment of amino acid residues of the S1 glycoprotein of IBV strains with the M41 strain

From: Phylogenetic distribution and predominant genotype of the avian infectious bronchitis virus in China during 2008-2009

Strains Deletions1 Insertions2 Cleavage recognition motifs
CQ8   119(2)GL, 140(2)NS RRTGRa
CQ9 21(1)D, 118(1)G 72(7)YTNGNDV HRRRRb
MS1 21(1)D, 118(1)G 72(7)YTNGNDV HRRRRb
PT1 21(1)D, 118(1)G 72(7)YTNGNDV RRSRRc
PT2   117(2)GV, 286(1)N RRLRRd
PT3 21(1)D, 118(1)G 72(7)YTNGNDV RRSRRc
PT4 21(1)D, 118(1)G 72(7)YTNGNDV RRSRRc
BT   119(2)GS RRFRRe
Y4   117(2)GI, 286(1)N RRFRRe
Y9   117(2)GI, 286(1)N RRFRRe
FML 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
HY   117(2)GV, 286(1)N RRLRRd
HY41 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
HY42 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
HY51 23(1)S, 118(1)G 72(7)YTNGNDV, 286(1)G RRFRRe
HY52 23(1)S, 118(1)G 72(7)YSNGNDV RRSKRf
HY1 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
HY2 23(1)S, 118(1)G 72(7)YSNGNDV RRSKRf
HY3 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
KY   24(1)N, 119(2)GS HRRRRb
LZ1   24(1)N, 119(2)GS HRRRRb
LZ2   24(1)N, 119(2)GS HRRRRb
LZ3   24(1)N, 119(2)GS HRRRRb
LH 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
SL   24(1)N, 119(2)GS HRRRRb
ST1   119(2)GS RRFRRe
ST3   119(2)GS RRFRRe
WL 21(1)D, 118(1)G 72(7)YTNGNDV HRRRRb
XD2   119(2)GS RRFRRe
XD3   24(1)N, 119(2)GS RRFRRe
XN   24(1)N, 119(2)GS RRFRRe
XN1   25(1)N, 119(2)GS HRRRRb
XN2   119(2)GS RRFRRe
GL1 21(1)D, 118(1)G 72(7)YTNGNDV HRRRRb
GL2   117(2)GI, 289(1)N RRLRRd
GL   25(1)N, 119(2)GS HRRRRb
HEZ 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
LC 118(1)G 72(7)YTNGNDV, 286(1)S RRFRRe
LC1   117(2)GI RRFRRe
LC2   117(2)GI RRFRRe
LC3   117(2)GI RRFRRe
LC4   117(2)GI RRFRRe
LC5   117(2)GI RRFRRe
LC6 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
LC7   117(2)GI RRFRRe
LC8   117(2)GI RRFRRe
LC9 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
NN   117(2)GI, 286(1)N RRLRRd
YL08   117(2)GI, 286(1)N RRLRRd
YL4 24(1)S, 118(1)G 72(7)YTNGNDV RRFRRe
YL6   24(1)N, 119(2)GS HRRRRb
HN08   119(2)GS RRFRRe
HN1 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
HN2 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
HN31 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
HN32 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
HN33 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
HN34 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
HN41 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
HN42 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
HN43 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
HN44 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
WH1   24(1)N, 119(2)GS HRRRRb
WH2   24(1)N, 119(2)GS HRRRRb
WH3   25(1)N, 119(2)GS HRRRRb
WH4   25(1)N, 119(2)GS HRRRRb
LYG   25(1)N, 119(2)GS HRRRRb
NJ    RRFRRe
HZ1   25(1)N, 119(2)GS HRRRRb
HZ2   25(1)N, 119(2)GS HRRRRb
HZ3   25(1)N, 119(2)GS HRRRRb
HZ4 21(1)D, 118(1)G 72(7)YTNGNDV RRFRRe
HZ5   25(1)N, 119(2)GS HRRRRb
HZ6   25(1)N, 119(2)GS HRRRRb
HZ7   25(1)N, 119(2)GS HRRRRb
HZ8   25(1)N, 119(2)GS HRRRRb
HZ9   25(1)N, 119(2)GS HRRRRb
QZ1   24(1)N, 119(2)GS HRRRRb
QZ2   24(1)N, 119(2)GS HRRRRb
QZ3   24(1)N, 119(2)GS HRRRRb
  1. 1 positions of residues in deduced amino acid sequences of the S1 protein of the M41 vaccine strain;
  2. 2 positions of residues in deduced amino acid sequences of the S1 protein of the M41 strain between which the residue(s) of other IBVs was (were) inserted.
  3. a, RRTGR: Arg-Arg-Thr-Gly-Arg (1/80); b, HRRRR: His-Arg-Arg-Arg-Arg (28/80); c, RRSRR: Arg-Arg-Ser-Arg-Arg (3/80); d, RRLRR: Arg-Arg-Leu-Arg-Arg 5/80; e, RRFRR: Arg-Arg-Phe-Arg-Arg (41/80); f, RRSKR Arg-Arg-Ser-Lys-Arg (2/80).